journal
MENU ▼
Read by QxMD icon Read
search

P & T: a Peer-reviewed Journal for Formulary Management

journal
https://www.readbyqxmd.com/read/30271108/research-briefs
#1
(no author information available yet)
No abstract text is available yet for this article.
October 2018: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/30271107/european-society-of-cardiology-congress-2018
#2
Walter Alexander
We review sessions on large-scale aspirin and anticoagulation trials, weight loss therapies, fish oil, gout, endocarditis, and cardiomyopathy, with important implications for health care providers.
October 2018: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/30271106/emerging-therapies-for-patients-with-difficult-to-treat-migraine
#3
Troy Kish
The landscape of migraine therapy is set to change with the introduction of new classes of medications aimed at providing options for patients who have not responded to previous therapies. However, the pricing of the new agents will likely be a key determinant in the extent of their use in clinical practice.
October 2018: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/30271105/enoxaparin-dosing-and-antixa-monitoring-in-specialty-populations-a-case-series-of-renal-impaired-extremes-of-body-weight-pregnant-and-pediatric-patients
#4
Tania Ahuja, Katie Mariam Mousavi, Liana Klejmont, Sonya Desai
The use of enoxaparin in specialty populations-including those with renal dysfunction, extremeness of body weight, pregnant patients, and pediatric patients-has not been studied in clinical trials. Monitoring anti-factor Xa activity (antiXa) as a surrogate to measure the activity of enoxaparin may be of interest. A case series of patients admitted to New York University Langone Health between December 2012 and July 2014 who received at least three consecutive doses of enoxaparin for the treatment of VTE and had a peak antiXa level drawn at steady state were evaluated...
October 2018: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/30271104/views-conflict-on-trump-s-drug-pricing-blueprint-most-actions-face-political-legal-and-technical-roadblocks
#5
Stephen Barlas
President Donald Trump's wide-ranging Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs has implications for P&T committees, PBMs, drug manufacturers, insurers, and of course, patients. As with everything else involving health care, it's complicated.
October 2018: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/30271103/naldemedine-symproic-for-the-treatment-of-opioid-induced-constipation
#6
Kenneth Hu, Mary Barna Bridgeman
Naldemedine (Symproic) for opioid-induced constipation.
October 2018: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/30271102/pharmaceutical-approval-update
#7
Mary Choy
Ivosidenib (Tibsovo) for acute myeloid leukemia; elagolix (Orilissa) for endometriosis; and mogamulizumab-kpkc (Poteligeo) for mycosis fungoides or S├ęzary syndrome.
October 2018: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/30271101/drug-and-device-news
#8
(no author information available yet)
Approvals, new indications, regulatory activities, and more.
October 2018: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/30271100/fda-finalizes-drug-communication-guidance-p-t-committees-can-receive-data-beyond-the-drug-label
#9
Stephen Barlas
The FDA has made it easier for P&T committees to make formulary coverage decisions by expanding the health care economics information that drug manufacturers can provide to them.
October 2018: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/30271099/selected-medication-safety-risks-that-can-easily-fall-off-the-radar-screen-part-2
#10
Matthew Grissinger
Part 2 of a 3-part series discusses medication safety risks related to labeling, patient education, and medication storage.
October 2018: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/30186029/research-briefs
#11
(no author information available yet)
No abstract text is available yet for this article.
September 2018: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/30186028/23rd-congress-of-the-european-hematology-association
#12
Walter Alexander
We review key sessions on multiple myeloma, chronic lymphocytic leukemia, Hodgkin lymphoma, Epstein-Barr virus-positive post-transplant lymphoma, and follicular lymphoma.
September 2018: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/30186027/poly-adp-ribose-polymerase-inhibitors-in-the-management-of-ovarian-cancer-a-drug-class-review
#13
J Tanner Ringley, Donald C Moore, Jolly Patel, Maegan S Rose
Objective: To review the pharmacology, safety, efficacy, and role of poly adenosine diphosphate [ADP]-ribose polymerase (PARP) inhibitors in the treatment and maintenance of relapsed, advanced ovarian cancer. Summary: A total of 3 phase 2 trials and 2 phase 3 trials were reviewed that evaluated the safety and efficacy of oral niraparib, olaparib, and rucaparib in patients with ovarian cancer. Progression-free survival (PFS) was evaluated in the maintenance setting for niraparib and olaparib, resulting in a PFS of 21...
September 2018: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/30186026/challenges-to-the-u-s-health-care-system-from-legal-and-regulatory-changes-in-the-donald-trump-era
#14
F Randy Vogenberg, Rita Marcoux
Despite a slow legislative start by President Trump, new federal and state regulatory health care changes will have important implications for pharmacists, P&T committees, and patients.
September 2018: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/30186025/congress-readying-user-fee-program-for-otc-products-money-needed-to-dig-fda-out-of-its-review-ditch
#15
Stephen Barlas
Questions about the safety and efficacy of cough and cold medicines and numerous other over-the-counter (OTC) products-along with an overwhelmed, understaffed FDA-are the driving force behind Congressional action to put a first-ever OTC user fee program in place.
September 2018: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/30186024/dupilumab-dupixent-an-interleukin-4-receptor-antagonist-for-atopic-dermatitis
#16
Daniella D'Ippolito, Michele Pisano
Dupilumab (Dupixent) for atopic dermatitis.
September 2018: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/30186023/pharmaceutical-approval-update
#17
Michele B Kaufman
Baricitinib (Olumiant) tablets for rheumatoid arthritis; plazomicin (Zemdri) injection for complicated urinary tract infections; and cannabidiol (Epidiolex) oral solution for seizures with Lennox-Gastaut syndrome and Dravet syndrome.
September 2018: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/30186022/drug-and-device-news
#18
(no author information available yet)
Approvals, new indications, regulatory activities, and more.
September 2018: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/30186021/wide-ranging-trump-drug-price-reduction-blueprint-controversial-issues-included-some-excluded
#19
Stephan Barlas
President Trump's American Patients First plan to reduce drug prices has some innovative aspects but might face political roadblocks.
September 2018: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/30186020/selected-medication-safety-risks-that-can-easily-fall-off-the-radar-screen
#20
Matthew Grissinger
Part 1 of a 3-part series discusses 3 medication safety risks that can easily fall off the radar screen in hospitals and doctors' offices.
September 2018: P & T: a Peer-reviewed Journal for Formulary Management
journal
journal
30579
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"